Raymond James & Associates’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-27,435
| Closed | -$633K | – | 4023 |
|
|
2021
Q1 | $633K | Buy |
27,435
+17,031
| +164% | +$393K | ﹤0.01% | 2828 |
|
|
2020
Q4 | $257K | Buy |
+10,404
| New | +$257K | ﹤0.01% | 3201 |
|
|
2020
Q3 | – | Sell |
-64,829
| Closed | -$3.11M | – | 3569 |
|
|
2020
Q2 | $3.11M | Sell |
64,829
-43,992
| -40% | -$2.11M | ﹤0.01% | 1464 |
|
|
2020
Q1 | $6.85M | Sell |
108,821
-15,543
| -12% | -$979K | 0.01% | 897 |
|
|
2019
Q4 | $15.4M | Buy |
124,364
+16,420
| +15% | +$2.03M | 0.02% | 692 |
|
|
2019
Q3 | $7.16M | Buy |
107,944
+20,095
| +23% | +$1.33M | 0.01% | 1034 |
|
|
2019
Q2 | $6.99M | Buy |
87,849
+15,019
| +21% | +$1.2M | 0.01% | 1048 |
|
|
2019
Q1 | $8.15M | Sell |
72,830
-15,931
| -18% | -$1.78M | 0.01% | 923 |
|
|
2018
Q4 | $8.95M | Buy |
88,761
+10,550
| +13% | +$1.06M | 0.02% | 809 |
|
|
2018
Q3 | $9.88M | Sell |
78,211
-265
| -0.3% | -$33.5K | 0.02% | 834 |
|
|
2018
Q2 | $6.59M | Buy |
78,476
+324
| +0.4% | +$27.2K | 0.01% | 1032 |
|
|
2018
Q1 | $4.81M | Buy |
78,152
+44,079
| +129% | +$2.71M | 0.01% | 1175 |
|
|
2017
Q4 | $1.99M | Buy |
+34,073
| New | +$1.99M | ﹤0.01% | 1697 |
|
|
2017
Q2 | – | Sell |
-1,949
| Closed | -$220K | – | 3267 |
|
|
2017
Q1 | $220K | Buy |
+1,949
| New | +$220K | ﹤0.01% | 2859 |
|